How do you pay?

How to pay the least

Ask for the cash price

Rezlidhia

We didn’t find one.

  1. Ask your pharmacy for Rezlidhia’s cash price, and one or two other pharmacies too.
  2. Rezlidhia’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameRezlidhia
Authorized genericolutasidenib
Regular genericolutasidenib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Rezlidhia?
The original
–
–

Brand nameThe maker’s card

REZLIDHIA Copay Assistance (RIGEL ONECARE)

Savings card from Rigel Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on rigelonecare.com 

See the offer on rezlidhia.com

In the maker’s words

“Eligible patients with commercial insurance pay as little as $0 per prescription dispense with REZLIDHIA copay assistance.”

From the maker’s offer on rezlidhia.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Rezlidhia itself, from the same company, sold without the brand name, and usually for less. For now Rezlidhia is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

REZLIDHIA is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test.

Source: the FDA label for Rezlidhia (Rigel Pharmaceuticals, Inc.), November 5, 2025. Full label on DailyMed 

Good to know